Evidence map›Paper›PMID 36432092›Full record

ReviewMolecules (Basel, Switzerland)2022

Oral Cell-Targeted Delivery Systems Constructed of Edible Materials: Advantages and Challenges.

Xiaolong Li, Zihao Wei, Changhu Xue

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Xiaolong LiCollege of Food Science and Engineering, Ocean University of China, Qingdao 266003, China.
Zihao WeiCollege of Food Science and Engineering, Ocean University of China, Qingdao 266003, China.ORCID 0000-0002-1942-7907
Changhu XueCollege of Food Science and Engineering, Ocean University of China, Qingdao 266003, China.

Funding

China Postdoctoral Science Foundation funded project 2021M693025Fundamental Research Funds for the Central Universities 202112006Marine S&T Fund of Shandong Province for Pilot National Laboratory for Marine Science and Technology (Qingdao) 2022QNLM030002National Key R&D Program of China 2018YFC0311201Natural Science Foundation of Shandong Province 2022HWYQ-068Natural Science Foundation of Shandong Province ZR2021QC077Qingdao Postdoctoral Application Foundation funded project 862005040044Start-up fund from Ocean University of China 862001013134
6 · The paper itself

Abstract

Cell-targeted delivery is an advanced strategy which can effectively solve health problems. However, the presence of synthetic materials in delivery systems may trigger side effects. Therefore, it is necessary to develop cell-targeted delivery systems with excellent biosafety. Edible materials not only exhibit biosafety, but also can be used to construct cell-targeted delivery systems such as ligands, carriers, and nutraceuticals. Moreover, oral administration is the appropriate route for cell-targeted delivery systems constructed of edible materials (CDSEMs), which is the same as the pattern of food intake, resulting in good patient compliance. In this review, relevant studies of oral CDSEMs are collected to summarize the construction method, action mechanism, and health impact. The gastrointestinal stability of delivery systems can be improved by anti-digestible materials. The design of the surface structure, shape, and size of carrier is beneficial to overcoming the mucosal barrier. Additionally, some edible materials show dual functions of a ligand and carrier, which is conductive to simplifying the design of CDSEMs. This review can provide a better understanding and prospect for oral CDSEMs and promote their application in the health field.

Indexed as

Administration, OralDrug Delivery SystemsContainment of BiohazardsHumansbiosafetycell targetinggastrointestinal tractmucosal barriernutraceuticalsoral administration

Identifiers

PMID36432092
PMCPMC9697699

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.